BVF as of Sept. 30, 2020
Portfolio Holdings for BVF
BVF holds 62 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Relay Therapeutics (RLAY) | 7.8 | $144M | 3.4M | 42.59 | |
| Springworks Therapeutics (SWTX) | 5.3 | $98M | 2.1M | 47.67 | |
| Repare Therapeutics Ord (RPTX) | 5.1 | $94M | 3.1M | 30.77 | |
| Kymera Therapeutics (KYMR) | 4.6 | $85M | 2.6M | 32.31 | |
| Xencor (XNCR) | 4.4 | $80M | 2.1M | 38.79 | |
| Xoma Corp Del Com New (XOMA) | 4.3 | $79M | 4.2M | 18.84 | |
| Revolution Medicines (RVMD) | 4.0 | $73M | 2.1M | 34.80 | |
| Cytokinetics Com New (CYTK) | 3.9 | $72M | 3.3M | 21.65 | |
| Merus N V (MRUS) | 3.7 | $68M | 5.6M | 12.00 | |
| Ac Immune Sa SHS (ACIU) | 2.6 | $48M | 9.8M | 4.88 | |
| Protagonist Therapeutics (PTGX) | 2.5 | $46M | 2.4M | 19.55 | |
| Kura Oncology (KURA) | 2.5 | $46M | 1.5M | 30.64 | |
| Celldex Therapeutics Com New (CLDX) | 2.5 | $46M | 3.1M | 14.83 | |
| Argenx Se Sponsored Adr (ARGX) | 2.4 | $45M | 170k | 262.52 | |
| Arcus Biosciences Incorporated (RCUS) | 2.4 | $45M | 2.6M | 17.14 | |
| Immunovant (IMVT) | 2.3 | $42M | 1.2M | 35.19 | |
| Ideaya Biosciences (IDYA) | 2.2 | $41M | 3.2M | 12.56 | |
| Replimune Group (REPL) | 2.1 | $39M | 1.7M | 23.02 | |
| Xenon Pharmaceuticals (XENE) | 2.1 | $39M | 3.5M | 11.07 | |
| Forte Biosciences (FBRX) | 2.1 | $38M | 778k | 48.51 | |
| Five Prime Therapeutics | 2.1 | $38M | 8.0M | 4.70 | |
| Syndax Pharmaceuticals (SNDX) | 2.0 | $37M | 2.5M | 14.76 | |
| Ionis Pharmaceuticals (IONS) | 1.9 | $35M | 735k | 47.45 | |
| Sutro Biopharma (STRO) | 1.7 | $31M | 3.1M | 10.05 | |
| Alx Oncology Hldgs (ALXO) | 1.3 | $24M | 639k | 37.74 | |
| Cytomx Therapeutics (CTMX) | 1.3 | $24M | 3.6M | 6.65 | |
| Molecular Templates | 1.3 | $24M | 2.1M | 10.92 | |
| Glycomimetics (GLYC) | 1.2 | $22M | 7.2M | 3.07 | |
| Selecta Biosciences (RNAC) | 1.1 | $21M | 8.5M | 2.48 | |
| Ovid Therapeutics (OVID) | 1.1 | $21M | 3.6M | 5.74 | |
| Essa Pharma Com New (EPIX) | 1.1 | $21M | 3.0M | 6.90 | |
| Infinity Pharmaceuticals (INFIQ) | 1.1 | $20M | 17M | 1.17 | |
| Anaptysbio Inc Common (ANAB) | 1.0 | $18M | 1.2M | 14.75 | |
| Calliditas Therapeutics Ab Sponsored Ads (CALT) | 1.0 | $18M | 750k | 24.00 | |
| Calithera Biosciences | 0.9 | $16M | 4.6M | 3.45 | |
| Spero Therapeutics (SPRO) | 0.8 | $15M | 1.3M | 11.16 | |
| Cti Biopharma | 0.8 | $15M | 6.9M | 2.15 | |
| Therapeutics Acquisition Cor Com Cl A | 0.8 | $14M | 1.0M | 14.38 | |
| Verastem | 0.7 | $13M | 11M | 1.21 | |
| Mei Pharma Com New | 0.7 | $13M | 4.1M | 3.12 | |
| Phathom Pharmaceuticals (PHAT) | 0.6 | $12M | 322k | 36.67 | |
| Pieris Pharmaceuticals (PIRS) | 0.6 | $11M | 5.5M | 2.07 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.6 | $11M | 3.8M | 2.85 | |
| Panacea Acquisition Corp Unit 99/99/9999 | 0.5 | $9.6M | 800k | 12.00 | |
| Genocea Biosciences Com New (GNCAQ) | 0.5 | $9.2M | 4.0M | 2.29 | |
| Gamida Cell SHS (GMDA) | 0.5 | $8.9M | 2.1M | 4.15 | |
| Contrafect Corp Com New | 0.5 | $8.4M | 1.6M | 5.28 | |
| Bctg Acquisition Corp | 0.5 | $8.3M | 800k | 10.36 | |
| Corvus Pharmaceuticals (CRVS) | 0.4 | $7.0M | 1.7M | 4.01 | |
| Evelo Biosciences | 0.4 | $6.9M | 1.3M | 5.27 | |
| Galmed Pharmaceuticals SHS | 0.3 | $6.4M | 1.8M | 3.53 | |
| X4 Pharmaceuticals (XFOR) | 0.3 | $5.4M | 793k | 6.77 | |
| Amarin Corp Spons Adr New (AMRN) | 0.3 | $4.6M | 1.1M | 4.21 | |
| Curis Com New | 0.2 | $4.3M | 3.7M | 1.17 | |
| Forward Pharma A/s Sponsord Ads New | 0.2 | $4.0M | 647k | 6.23 | |
| Erytech Pharma Sponsored Adr | 0.2 | $3.9M | 625k | 6.25 | |
| Novus Therapeutics | 0.2 | $3.3M | 3.5M | 0.95 | |
| Biolinerx Sponsored Ads (BLRX) | 0.2 | $2.8M | 1.7M | 1.64 | |
| Sunesis Pharmaceuticals Com New | 0.1 | $2.2M | 1.7M | 1.25 | |
| Regulus Therapeutics Com New | 0.1 | $1.7M | 3.2M | 0.51 | |
| Spring Bk Pharmaceuticals In | 0.1 | $1.3M | 941k | 1.34 | |
| Exelixis (EXEL) | 0.0 | $374k | 15k | 24.44 |
